Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D
ClinicalTrials.gov study NCT05210530. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Investigation of Efficacy of Improved Acetaminophen Labeling
ClinicalTrials.gov study NCT01592448. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or i
ClinicalTrials.gov study NCT02143882. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03533283. IPD Sharing: YES. Countries: 6. Publications: 1.
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Gi
ClinicalTrials.gov study NCT01745965. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
ClinicalTrials.gov study NCT00779116. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
ClinicalTrials.gov study NCT02226120. IPD Sharing: UNDECIDED. Countries: 41. Publications: 0.
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
ClinicalTrials.gov study NCT05806554. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
ClinicalTrials.gov study NCT02018510. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
ClinicalTrials.gov study NCT05933070. IPD Sharing: NO. Countries: 2. Publications: 25.
Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical T
ClinicalTrials.gov study NCT06481566. IPD Sharing: NO. Countries: 1. Publications: 5.
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults
ClinicalTrials.gov study NCT05894902. IPD Sharing: NO. Countries: 1. Publications: 36.
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
ClinicalTrials.gov study NCT04878211. IPD Sharing: YES. Countries: 1. Publications: 0.
Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Th
ClinicalTrials.gov study NCT00000678. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
ClinicalTrials.gov study NCT03986762. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Comparing Front-of-package Nutrient Labels
ClinicalTrials.gov study NCT06903403. IPD Sharing: NO. Countries: 1. Publications: 0.
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elde
ClinicalTrials.gov study NCT04751877. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT02647086. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
ClinicalTrials.gov study NCT00586651. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination
ClinicalTrials.gov study NCT01618136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.